 The chemical structure differs from other NSAIDs in that the central benzene ring has been replaced by a pyrrole.Zomepirac is a prostaglandin synthetase inhibitor.Zomepirac does not cause anaphylaxis directly, but it is metabolized by UDP-glucuronosyltransferase (UGT) to a reactive glucuronide which binds irreversibly to plasma albumin.